Adaptimmune Therapeutics's market cap is currently $38.96M. The company's EPS TTM is $-0.02; its P/E ratio is ―; Adaptimmune Therapeutics is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in USD
Adaptimmune Therapeutics Earnings and Revenue History
